Journals / İnfeksiyon Dergisi / 2002 / Cilt: 16 - Sayı: 4

Parkinsonlu hastalarda subklinik Helicobacter pylori seropozitivitesi

Subclinical Helicobacter pylori seropositivity in patients with parkinson's disease

Pages
435–438
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Only three patients had IgM seropositivity for H. pylori although none of the control group had IgM seropositivity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Helicobacter pylori, the organism associated with peptic ulceration, is responsible for the pathogenesis of Parkinson's Disease.
📊
Key Findings & Data:Nineteen selected patients with Parkinson's Disease, using levodopa, who had not had gastric complaints or previous peptic ulcus diagnosis and age matched 21 healthy volunteers were included in the study.
💡
Conclusion & Impact:Only three patients had IgM seropositivity for H. pylori although none of the control group had IgM seropositivity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Helicobacter pylori, the organism associated with peptic ulceration, is responsible for the pathogenesis of Parkinson's Disease. This cross-sectional case control study was planned to investigate the frequency of subclinical H. pylori seropositivity in patients with Parkinson's Disease. Nineteen selected patients with Parkinson's Disease, using levodopa, who had not had gastric complaints or previous peptic ulcus diagnosis and age matched 21 healthy volunteers were included in the study. Specific IgM and IgG antibodies for H. pylori were measured by enzyme-linked immunosorbent assay. The majority of the patients (12 patients - 63.2%) had advanced (severe) stage of Parkinson's Disease. Three patients in Parkinson's Disease group and five subjects in the control group had IgG seropositivity for H. pylori. There was no significant difference between the groups in respect to IgG seropositivity (p>0.05). Only three patients had IgM seropositivity for H. pylori although none of the control group had IgM seropositivity.

Özet

Peptik ülserden sorumlu tutulan Helicobacter pylori, Parkinson Hastalığı patogenezinde de rol oynar. Bu olgu-kontrol çalışması, Parkinsonlu hastalardaki subklinik H. pylori seropozitifliğini araştırmak için planlanmıştır. Parkinson Hastalığı olan ve levodopa kullanan 19 hasta ve 21 sağlıklı gönüllü çalışmaya alınmıştır. Enzim-bağlı immunosorbent tarama yöntemiyle, H. pylori'ye özgü IgM ve IgG antikorları ölçülmüştür. Hastaların çoğunda Parkinson Hastalığı ileri devredeydi (12 hasta-% 63.2). Parkinsonlu hastaların üçünde, kontrol grubunun beşinde H. pylori'ye özgü IgG seropozitivitesi bulundu. Gruplar arasında IgG seropozitivitesi açısından anlamlı fark yoktu (p> 0.005). Hastalarda herhangi bir gastrik yakınma olmasa da, H. pylori infeksiyonunun, Parkinson Hastalığı patogenezinde ve levadopa yanıtında önemli, bazende ihmal edilebilecek rol oynadığı sonucuna varıldı.

🔖

Cite This Article

ÖZTÜRK, C., DELİALİOĞLU, N., BUĞDAYCI, R., KALEAĞASI, H., ÖZGE, A. (2022). Parkinsonlu hastalarda subklinik Helicobacter pylori seropozitivitesi. İnfeksiyon Dergisi, Cilt: 16 - Sayı: 4, 435–438. https://ajindex.com/articles/546712

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...